Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Zhong Xi Yi Jie He Xue Bao ; 3(2): 154-9, 2005 Mar.
Article in Zh | MEDLINE | ID: mdl-15763068

ABSTRACT

The problem on study of the active and toxic constituents of Chinese materia medica is the core of the problems in the field of modern research of Chinese materia medica. But approved methods for ascertaining the active and toxic constituents in Chinese materia medica have not been developed yet and are in developing phases. In combination with the characteristics of Chinese materia medica in clinical use and the achievements of modern pharmaceutical research, series model may be a finer approach to make certain of the active and toxic constituents from Chinese materia medica, which includes the parent compound biotransformation by human intestinal bacteria to make biotransformation products, and the absorption and further biotransformation in intestinal wall, the metabolization in the liver, and the secretion by the kidney of the parent compounds and biotransformation products. This method is also an important research assignment in the field of experimental medicine study of Chinese materia medica.


Subject(s)
Aristolochic Acids/pharmacokinetics , Drugs, Chinese Herbal/pharmacokinetics , Glycyrrhizic Acid/pharmacokinetics , Materia Medica , Aristolochic Acids/adverse effects , Aristolochic Acids/chemistry , Biotransformation , DNA Adducts/adverse effects , Drugs, Chinese Herbal/chemistry , Humans , Intestinal Mucosa/metabolism , Intestines/microbiology , Research Design
SELECTION OF CITATIONS
SEARCH DETAIL